You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Thermal Spray Dashboard/Knowledge Management System

    SBC: ENGINEERING AND SOFTWARE SYSTEM SOLUTIONS, INC.            Topic: AF151166

    The USAF repair depots expend tremendous amounts of resources applying high technology thermal spray coatings to improve the performance of components and systems. In general, thermal spray application processes are complex, requires high cost equipment that are expensive to operate, need highly trained personnel and necessitate constant verification testing to ascertain the coatings meet requirem ...

    SBIR Phase II 2017 Department of DefenseAir Force
  2. Guidance, Navigation and Control Algorithms and Hardware for Advanced Interceptors

    SBC: Space Information Laboratories, LLC            Topic: MDA11012

    Space Information seeks to develop open, modular, reconfigurable, and reduced-SWAP avionics systems that operate in extreme environments. Missile defense applications require a global launch approach that removes the need for fixed, ground based range instrumentation operation assets (Radar, Telemetry, Flight Termination System (FTS) and Optics) to reduce life cycle cost for multiple vehicle test ...

    SBIR Phase II 2017 Department of DefenseMissile Defense Agency
  3. Military Distributed Array Reach-back using Time Reversal (m-DART)

    SBC: ZIVA CORPORATION            Topic: SB132004

    Ziva proposes to develop and demonstrate a novel and powerful approach called Military Distributed Array Reach-back using Time Reversal (m-DART) which enables extension of communication range for both TX and RX in a scaled down A2/AD scenario on a small size, weight, and power (SWaP) distributed unmanned aerial system (UAS). The overall objective of m-DART Phase II/Option is to develop and demonst ...

    SBIR Phase II 2017 Department of DefenseDefense Advanced Research Projects Agency
  4. Long-acting PTH for hypoparathyroidism

    SBC: EXTEND BIOSCIENCES INC            Topic: NIDDK

    Project Summary Hypoparathyroidism is a rare disease that results from a deficiency or inability to make sufficient amounts of parathyroid hormonePTHUntreated or inadequately treated hypoparathyroidism leads to clinically significant mineral related metabolic issues including hypocalcemiawhich leads to heart arrhythmiasspasms of the vocal cordsand seizuresCurrent management of the disease for the ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  5. Development of PAR2 Pepducins as a Novel NASH Treatment

    SBC: OASIS PHARMACEUTICALS, LLC            Topic: 300

    Non alcoholic steatohepatitisNASHis characterized by fatty changes in the liver with inflammation and hepatocellular injury that in advanced stages leads to fibrosiscirrhosis and high mortality ratesNASH is frequently associated with other common metabolic abnormalitiessuch as insulin resistance and visceral obesityLiver transplantation is currently the only effective therapeutic approach for seve ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  6. Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection

    SBC: EPIPHANY BIOSCIENCES, INC.            Topic: R

    Project Summary Abstract Kaposiandapos s sarcoma herpes virusKSHVis an oncovirus that causes several cancers including Kaposiandapos s sarcomaKSIt is estimated thattoof U Sblood donors have been infected with KSHVyet in some high risk populations such as homosexual menprevalence is as high asIn spite of HAARTKS remains the second most common AIDSassociated malignancyA third of AIDS KS cases now ar ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. Highly sensitive measurement of cTnI without a reader: the Xip solution

    SBC: SILICON BIODEVICES, INC.            Topic: NHLBI

    Project Summary Acute myocardial infarction (MI) is the biggest killer in the western world and is the cause of death for nearly 500,000 Americans each year. The symptoms of MI can be vague and non- specific and 7 million adults present to hospital Emergency Departments in the US each year with suspected MI. Advances in cardiac biomarkers have had a large impact on the diagnosis, risk stratificati ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. MR191_An Immunoprotectantfor Marburg Virus

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: NIAID

    PROJECT SUMMARY Mapp BiopharmaceuticalIncMappis developing antibody based therapeutics to treat a number of infectious agentsincluding some of the most dangerous known to manthe filovirusesMarburg virus is a filovirus endemic to Africa and causes an often lethal hemorrhagic feverPresently there are no approved vaccines or therapeutics to treat Marburg virus infections and this remains a major unme ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Production Technology for Recombinant Intravenous Immunoglobulin

    SBC: Gigagen, Inc.            Topic: NIAID

    PROJECT SUMMARY Project TitleProduction Technology for Recombinant Intravenous Immunoglobulin OrganizationGigaGen IncPIDavid SJohnsonPh DIntravenous immunoglobulinor IVIgis a pool of antibodies isolated from the plasma of thousands of donorsIVIg therapy is used for several indicationsincluding B cell chronic lymphocytic leukemiaCLLautoimmune neuropathyand primary immunodeficiencyPIDIVIg sales are ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Therapeutic Antibodies for Biofilm Infections

    SBC: TRELLIS BIOSCIENCE, INC.            Topic: NIAID

    Abstract The CDC estimates thatof clinically significant drug resistant bacterial infections are drug refractory due to a change in physiological state of pathogens associated with biofilm formationTRLis a high affinitypMnative human monoclonal antibodymAbthat disrupts biofilms by extracting a key bacterial scaffolding proteinThe epitope is highly conserved in the target protein homologs across a ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government